@M4NDPharma retweeted
Interesting: @jftrempe & @mcgillu colleagues have received a grant from @AgoraOpenSci Medicines for Neurodegeneration (M4ND) @m4ndpharma to explore Parkin protein as a potential therapeutic target for #Parkinsons - #OpenScience drug discovery!
mcgill.ca/research/article/m…
@M4NDPharma retweeted
Open #Parkinsons drug discovery comes to @mcgillu! @M4NDPharma supports a project under terms that codify open access, rapid sharing, no patents. All with aim to invent medicines and be able to price them affordably. @MichaelJFoxOrg @ASAP_Research @KrembilF @AgoraOpenSci
We’re proud to partner with @jftrempe @mcgillu to support #openscience drug discovery for Parkinson’s disease! mcgill.ca/research/article/m…
@M4NDPharma retweeted
Slowly, surely, @thesgconline is putting together an externally-reviewed set of chemical probes, all highly annotated. Underappreciated is the fact that probe makers are doing a lot (lot) of work collating the accompanying data. It's actually these data that make the probe.
This Post is from an account that no longer exists. Learn more
@M4NDPharma retweeted
I’ll be talking about the @M4KPharma & @M4NDpharma open drug discovery business model and argue Canadian tax-payers should only support drug discovery efforts that commit to affordable pricing/global access. #openscience
#OpenScience is changing the way we do science. Learn more about how this innovative model is benefiting the work of @TheNeuro_MNI and @thesgconline, with @picardonhealth, @VivianePoupon, Inez Jabalpurwala @BrainCanada, @aledmedwards, @AbernsteinCIFAR ow.ly/nBRx50wQzZu
@M4NDPharma retweeted
So excited to be part of this. Our OpenAD center has made the decision not to patent anything, and to advance any promising lead to an affordably-priced medicine with @M4NDPharma, which will adopt the #openscience business model pioneered by @M4KPharma.
nia.nih.gov/news/nih-funded-…
@M4NDPharma retweeted
In the NYT, @JosephEStiglitz argues that capitalism must uplift all, not just the lucky few. This philosophy also drives our #openscience efforts. Science is for everyone, and access to affordable medicine is a human right.
@thesgconline @M4KPharma
nytimes.com/2019/04/19/opini…
@M4NDPharma retweeted
Forgoing Patents, Open Science Firm @thesgconline and @aledmedwards Aim to Accelerate Drug Discovery buff.ly/2VN4mvZ @AAASmeetings
@M4NDPharma retweeted
Read about our #OpenScience drug discovery and drug development approach in Pharmaceutical Technology today! @m4ndpharma @thesgconline @aledmedwards pharmaceutical-technology.co…
@M4NDPharma retweeted
Forgoing Patents, Open Science Firm Aims to Accelerate Drug Discovery
rdmag.com/article/2019/04/fo… @RandDMagazine @M4KPharma
@m4ndpharma
@M4NDPharma retweeted
Remove the tax on Canadian #innovation: get #universities out of the #patenting business. Why #OpenScience collaborations will advance Canadian #innovation. By me: cigionline.org/articles/shou… @CIGIonline @thesgconline @TheNeuro_MNI @LawMcGill
@M4NDPharma retweeted
We are proud of the work that our partners @CRiverLabs are doing to support the fight for a #DIPG cure using #OpenScience !!
Our #EurekaBlog continues to explore the topic of childhood cancer. Learn more more about this unusual business model that encourages transparency and how they are trying to beat a rare and deadly childhood cancer. https://teapawt.net/t.co/KyvUjBv9NR
@M4NDPharma retweeted
Replying to @CRiverLabs
Thanks for all you're doing with all the collaborators on the @M4KPharma ALK2 project for #DIPG Grateful this is the first disease target & pleased to be of support to UK research efforts on this #ResearchMatters
@M4NDPharma retweeted
Thank you to our partners @CRiverLabs seen here on a video chat discussing our joint #OpenScience effort to #DefeatDIPG 🙏
DIPG is a brain stem tumor that is always fatal in children. What are we doing to try and change those dismal odds? Click here to watch our #EurekaBlog video to find out. https://teapawt.net/t.co/lKDjyle5nj
@M4NDPharma retweeted
The price of medicines and our societal conundrum. We laud start-up scene, the patent system, VC investors and “shareholder value” capitalism…but then complain when the system works as designed. We need a new system. #openscience @M4KPharma @m4ndpharma @thesgconline
@M4NDPharma retweeted
Open science is good business. We structured @M4KPharma and @M4NDpharma to access gov’t & foundation funding, but not VC funds. Annual gov’t & foundation funding for health R&D is 10x greater that annual health VC funding. #openscience companies have far more funding options.
@M4NDPharma retweeted
Drug prices too high? There is a long-term 🇨🇦 solution. @M4KPharma & @m4ndpharma were set up to test a new drug discovery business model based on #OpenScience and with a commitment to affordable pricing.
@KCroweCBC @OICR_news
@GenomeCanada @thesgconline
cbc.ca/news/health/pharmaceu…
@M4NDPharma retweeted
Medicines 4 Neurodegenerative Diseases will pursue promising new genetic drug targets for these intractable nervous system disorders https://teapawt.net/t.co/1x8sT8huKb
@M4NDPharma retweeted
Replying to @aledmedwards @m4ndpharma
After M4K Pharma, now M4ND Pharma. A new model is now well alive to develop affordable medicines. This is fantastic!

















